Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05847387
Other study ID # VC1
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 1, 2023
Est. completion date September 30, 2025

Study information

Verified date February 2024
Source Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Contact Matteo Airaldi, MD
Phone +390303995847
Email matteo.airaldi@unibs.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this international cohort study is to validate a new method for preoperative assessment of endothelial viability in donor corneal tissues for transplantation, and to correlate endothelial health as assessed by the surgical team to functional and structural long-term outcomes in the cohort of patients receiving them.


Description:

The corneal endothelium is responsible for preserving corneal transparency by maintaining a dynamic equilibrium of corneal stromal hydration. Corneal Endothelial Cells (CECs) health is approximated by evaluating the Endothelial Cell Density (ECD) of corneal tissues though specular biomicroscopy. ECD is a key determinant of long-term tissue survival after corneal transplantation, as corneal graft function is directly dependent on the number of viable CECs. However, ECD represents only an estimation of total corneal endothelial health and is a suboptimal proxy for future endothelial failure. In the current chain of supply of donor corneal tissues, no independent evaluation of endothelial cell viability by the surgical team tasked with transplanting the donor corneal tissue is anticipated. The investigators have previously shown a poor correlation between ECD declared by the eye bank providing the tissue and tissue quality as assessed independently by a cornea surgeon performing the transplantation (unpublished data). In this study, the investigators describe a simple method to independently evaluate the overall endothelial viability of donor corneal tissue which can be adopted both by eye banks before shipment and by the corneal surgeons before transplantation in the operating theatre. This method uses basic image analysis to assess the extent of endothelial cell death and/or denuded endothelial areas with the use of Trypan Blue, a vital dye commonly employed during corneal transplantation. Endothelial cell loss is visualized and quantified as Trypan Blue Positive Areas (TBPA). The primary objective of this study is to quantify the extent of TBPA in the operating theatre before corneal transplantation and correlate it to overall donor mortality declared by the eye bank. Secondary objectives include the assessment of the correlation of TBPA with declared ECD and CECs mortality, on folds, as well as the longitudinal analysis of endothelial cell loss as a function of time from surgery and initial TBPA over a follow-up of 12 months, final ECD, incidence of graft failure, and risk of graft failure attributable to preoperative TBPA.


Recruitment information / eligibility

Status Recruiting
Enrollment 135
Est. completion date September 30, 2025
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age older than 18 years old - Planned corneal transplantation: perforating keratoplasty (PK), Descemet stripping automated endothelial keratoplasty (DSAEK), ultra-thin DSAEK (UT-DSAEK) or Descemet membrane endothelial keratoplasty (DMEK) - Indication for corneal transplantation (low-moderate risk of rejection): keratoconus, Fuchs endothelial dystrophy - Ability to provide written informed consent. Exclusion Criteria: - Prior corneal transplantation - Planned preloaded DSAEK or preloaded DMEK - Planned keratoplasty not involving corneal endothelium transplantation (i.e., superficial/deep anterior lamellar keratoplasty) - Evidence of concurrent microbial keratitis - Evidence of non-infectious or autoimmune keratitis - Impending or frank corneal perforation - Uncontrolled, elevated intraocular pressure (IOP)- Previous glaucoma surgery - Acute or chronic inflammatory/infectious anterior segment uveitis - Presence of an anterior chamber intraocular lens (IOL) for phakic or aphakic purposes

Study Design


Intervention

Diagnostic Test:
V-Check
Preoperative analysis of endothelial tissue staining with vital dye (Trypan Blue 0.05%) and image analysis to identify the percentage of Trypan Blue Positive Areas, corresponding to dead endothelial cells and/or denuded areas of endothelium, in tissues destined to keratoplasty

Locations

Country Name City State
Belgium Antwerp University Hospital Edegem
Germany Department of Ophthalmology, University of Cologne Cologne
Germany Münster University Hospital Münster
Italy IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna
Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia Brescia BS
Italy Department of Medical and Surgical Sciences, University Magna Græcia Catanzaro
Italy Department of Experimental Medicine, Tor Vergata School of Medicine and Surgery Roma
Italy Fondazione Banca degli Occhi del Veneto Venice
Italy San Bortolo Hospital Vicenza
Netherlands Maastricht University Medical Center Maastricht
Spain Hospital Regional Universitario de Málaga Málaga
United Kingdom Royal Liverpool University Hospital Liverpool

Sponsors (1)

Lead Sponsor Collaborator
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Countries where clinical trial is conducted

Belgium,  Germany,  Italy,  Netherlands,  Spain,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Trypan Blue Positive Areas (TBPA) percentage and Donor mortality The comparison of the endothelial mortality of included donor corneas measured preoperatively (TBPA) and the overall endothelial mortality as declared by the eye bank providing the tissue Preoperative
Secondary Correlation of TBPA to declared endothelial cell density (dECD) Spearman's rank correlation coefficient of TBPA and declared Endothelial Cell Density (dECD) as provided by the Eye Bank supplying the tissue Preoperative
Secondary Correlation of TBPA to declared endothelial mortality on corneal folds Spearman's rank correlation coefficient of TBPA and declared Endothelial Cell mortality on corneal folds as provided by the Eye Bank supplying the tissue Preoperative
Secondary Final ECD Final ECD of transplanted corneas at 12 months 1 year after enrollment
Secondary Rate of endothelial cell loss Rate of change of ECD over the course of the entire follow-up 1 year after enrollment
Secondary Incidence of endothelial graft failure The occurrence of clinically definite corneal edema and/or need for endothelial keratoplasty due to endothelial failure 1 year after enrollment
Secondary Relative risk of endothelial graft failure associated with TBPA Calculation through a proportional hazard model of the relative risk of endothelial graft failure attributable to preoperatively measured TBPA Preoperative
See also
  Status Clinical Trial Phase
Completed NCT02470793 - Technique And Results In Endothelial Keratoplasty N/A
Completed NCT02276638 - Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality
Recruiting NCT04072978 - Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes
Completed NCT03107000 - Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy N/A
Not yet recruiting NCT05522842 - Corneal Endothelium in Diabetics Undergoing Phacoemulsification
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT05447130 - Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome N/A
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Completed NCT06396156 - Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support. N/A
Withdrawn NCT03361709 - Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density Phase 4
Completed NCT02427256 - Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Completed NCT02138266 - Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Completed NCT04396301 - Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco Phase 3
Recruiting NCT05119270 - Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces N/A
Recruiting NCT01726790 - Effect of Intravitreal Bevacizumab on Corneal Endothelium N/A